HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ilaria Badagnani Selected Research

CX-2029

1/2022Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ilaria Badagnani Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 10/2003
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Autoimmune Diseases (Autoimmune Disease)
08/2006

Drug/Important Bio-Agent (IBA)

1monomethyl auristatin EIBA
01/2022
1Janus Kinase InhibitorsIBA
01/2022
1AntigensIBA
01/2022
1CitrullineIBA
01/2022
1izencitinibIBA
01/2022
1CX-2029IBA
01/2022
1Valine (L-Valine)FDA Link
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Janus KinasesIBA
01/2022
1NAD (NADH)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Methotrexate (Mexate)FDA LinkGeneric
08/2006
1NucleosidesIBA
10/2003

Therapy/Procedure

2Therapeutics
01/2022 - 10/2003